Telehealth to improve asthma control in pregnancy: A randomized controlled trial.

Autor: Zairina E; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia.; Department of Pharmacy Practice, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia., Abramson MJ; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.; Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia., McDonald CF; Department of Respiratory and Sleep Medicine, The Austin Hospital, Heidelberg, Australia., Li J; Department of Electrical and Computer Systems Engineering, Faculty of Engineering, Monash University, Melbourne, Australia., Dharmasiri T; Department of Electrical and Computer Systems Engineering, Faculty of Engineering, Monash University, Melbourne, Australia., Stewart K; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia., Walker SP; Department of Maternal Fetal Medicine, Mercy Hospital for Women, Melbourne, Australia.; Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia., Paul E; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia., George J; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia.
Jazyk: angličtina
Zdroj: Respirology (Carlton, Vic.) [Respirology] 2016 Jul; Vol. 21 (5), pp. 867-74. Date of Electronic Publication: 2016 Mar 31.
DOI: 10.1111/resp.12773
Abstrakt: Background and Objective: Poorly controlled asthma during pregnancy is hazardous for both mother and foetus. Better asthma control may be achieved if patients are involved in regular self-monitoring of symptoms and self-management according to a written asthma action plan. Telehealth applications to optimize asthma management and outcomes in pregnant women have not yet been evaluated. This study evaluated the efficacy of a telehealth programme supported by a handheld respiratory device in improving asthma control during pregnancy.
Methods: Pregnant women with asthma (n = 72) from two antenatal clinics in Melbourne, Australia, were randomized to one of two groups: (i) intervention-involving a telehealth programme (management of asthma with supportive telehealth of respiratory function in pregnancy (MASTERY(©) )) supported by a handheld respiratory device and an Android smart phone application (Breathe-easy(©) ) and written asthma action plan or (ii) control-usual care. The primary outcome was change in asthma control at 3 and 6 months (prenatal). Secondary outcomes included changes in quality of life and lung function, and perinatal/neonatal outcomes.
Results: At baseline, participants' mean (± standard deviation) age was 31.4 ± 4.5 years and gestational age 16.7 ± 3.1 weeks. At 6 months, the MASTERY group had better asthma control (P = 0.02) and asthma-related quality of life (P = 0.002) compared with usual care. There were no significant differences between groups in lung function, unscheduled health-care visits, days off work/study, oral corticosteroid use, or perinatal outcomes. Differences between groups were not significant at 3 months.
Conclusion: Telehealth interventions supporting self-management are feasible and could potentially improve asthma control and asthma-related quality of life during pregnancy.
(© 2016 Asian Pacific Society of Respirology.)
Databáze: MEDLINE
Externí odkaz: